{
  "meta": {
    "id": "test70",
    "title": "Stomach (Carcinoma Stomach)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "True about Siewert classification is/are:",
      "options": [
        {
          "label": "A",
          "text": "Type I tumors are located between 2 and 5 cm caudal to the GE junction.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type II tumors have a tumor center located from 1 cm above the GE junction to 2 cm below it.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Type III tumors are tumors of the distal esophagus, within 1 to 5 cm above the GE junction",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "B. Type II tumors have a tumor center located from 1 cm above the GE junction to 2 cm below it.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Type II tumors have a tumor center located from 1 cm above the GE junction to 2 cm below it. The Siewert classification system is based on the anatomic location of adenocarcinomas (esophageal and gastric) that are in close proximity to the GE junction. This is an important distinction because such gastric cancers are more aggressive in nature and are treated in a similar manner to esophageal adenocarcinomas. There are three Siewert types: Option: A. Type I tumors are tumors of the distal esophagus, within 1 to 5 cm above the GE junction. Option: C. Type III tumors are termed sub cardinal and are located between 2 and 5 cm caudad to the GE junction Option: D. All of the above cannot be the answer. In general, Siewert types I and II tumors are treated similarly to esophageal adenocarcinoma, whereas type III tumors can be treated according to the guidelines for gastric adenocarcinoma described here, as long as the tumor does not extend into the GE junction.</p>\n<p><strong>Highyeild:</strong></p><p>The Siewert classification system categorizes adenocarcinomas near the GE junction. These cancers require similar treatment to esophageal adenocarcinomas due to their high level of aggression. The system consists of three types: type I, located in the distal esophagus; type II, with a tumor center located near the GE junction; and type III, located below the GE junction. Siewert types I and II are treated similarly to esophageal adenocarcinomas. Type III tumors can be treated following gastric adenocarcinoma guidelines if the tumor does not extend into the GE junction. These distinctions are incorporated into the current AJCC TNM staging guidelines.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2f329ea",
      "audio": ""
    },
    {
      "text": "Which of the following is true regarding Menetrier\u2019s disease:",
      "options": [
        {
          "label": "A",
          "text": "Premalignant condition",
          "correct": false
        },
        {
          "label": "B",
          "text": "Characterised by gross hypertrophy of gastric mucosal folds",
          "correct": false
        },
        {
          "label": "C",
          "text": "No treatment other than Gastrectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above MENETRIER\u2019S DISEASE: This is an unusual condition characterized by gross hypertrophy of the gastric mucosal folds, mucus production, and hypochlorhydria. The condition is premalignant and may present with hypoproteinaemia and anemia . There is no treatment other than a gastrectomy. The disease seems to be caused by overexpression of transforming growth factor alpha (TGF-\u03b1) . Like epidermal growth factor (EGF), this peptide also binds to the EGF receptor. The histological features of M\u00e9n\u00e9trier\u2019s disease may be reproduced in transgenic mice overexpressing TGF-\u03b1.</p>\n<p><strong>Highyeild:</strong></p><p>Menetrier's disease is a rare, acquired disorder of the stomach. It is characterized by hypertrophy of the gastric mucosa and a cobblestone or cerebriform appearance. The condition is typically associated with epigastric pain, anorexia, weight loss, and pedal edema. Menetrier's disease can also result in low total protein and albumin levels , which can lead to malnutrition and other complications. The overproduction of transforming growth factor alpha is believed to be the cause of the condition.</p>\n<p><strong>Extraedge:</strong></p><p>Diagnosis is made through endoscopy , which reveals massive gastric folds in the stomach. Treatment involves supportive care and symptomatic relief , and surgery may be necessary in severe cases.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28d3011b",
      "audio": ""
    },
    {
      "text": "Sunburst appearance in Radiography is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Serous cystic neoplasm",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mucinous cystic neoplasm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intraductal papillary mucinous neoplasm",
          "correct": false
        },
        {
          "label": "D",
          "text": "Adenocarcinoma",
          "correct": false
        }
      ],
      "correct_answer": "A. Serous cystic neoplasm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Serous cystic neoplasm Radiographic features: Serous Cystic Neoplasm: Central calcification, with radiating septa giving the sunburst appearance, is a radiographic sign on CT in 10% to 20% of patients.</p>\n<p><strong>Highyeild:</strong></p><p>Serous cystic neoplasm is a type of pancreatic cyst that is usually benign. It is typically found incidentally during imaging tests such as CT scans or MRIs. Serous cystic neoplasms are filled with clear, watery fluid and are typically small, measuring less than 2 inches in diameter. These cysts are most commonly found in middle-aged women and are often asymptomatic. In some cases, they can cause abdominal discomfort or fullness, nausea, or vomiting. While most serous cystic neoplasms are benign, some may have the potential to become cancerous over time. Monitoring and surveillance are often recommended for serous cystic neoplasms.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: B, C & D.  Mucinous Cystic Neoplasm: The radiologic characteristic of an MCN on a CT scan is the presence of a solitary cyst, which may have fine septations and be surrounded by a rim of calcification. Cross-sectional imaging may not be able to distinguish between benign and malignant MCNs; however, the presence of eggshell calcification, larger tumor size, or a mural nodule on cross-sectional imaging is suggestive of malignancy.</p>\n<p><strong>Extraedge:</strong></p><p>Treatment for serous cystic neoplasms typically involves periodic imaging tests to monitor the cyst's growth and potential for malignancy. Surgery may be recommended if the cyst is large or causing symptoms or if there is concern about the potential for malignancy. Overall, the prognosis for individuals with serous cystic neoplasms is generally good, as most cysts are benign and do not require treatment beyond monitoring.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4478dde",
      "audio": ""
    },
    {
      "text": "Amsterdam II criteria is used to diagnose:",
      "options": [
        {
          "label": "A",
          "text": "FAP",
          "correct": false
        },
        {
          "label": "B",
          "text": "HNPCC",
          "correct": true
        },
        {
          "label": "C",
          "text": "Peutz-Jeghers",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carcinoid",
          "correct": false
        }
      ],
      "correct_answer": "B. HNPCC",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>HNPCC HNPCC can be diagnosed by genetic testing or by the Amsterdam II criteria: Three or more family members with HNPCC-related cancer (colorectal, endometrial, small bowel, ureter, renal pelvis), one of whom is a first-degree relative of the other two; Two successive affected generations; At least one colorectal cancer diagnosed before the age of 50 years; FAP excluded; Tumors verified by pathological examination. Patients with HNPCC are offered regular endoscopic surveillance. The small intestine may also be radiologically assessed but this is of unproven benefit.</p>\n<p><strong>Highyeild:</strong></p><p>The Amsterdam II criteria is used to identify individuals who may have Lynch syndrome. Lynch syndrom e is an inherited genetic disorder that increases the risk of developing certain types of cancer. The criteria include having three or more family members with Lynch syndrome-related cancer, with at least one being a first-degree relative of the other two. Having two or more successive affected generations in the family is also a criterion . At least one Lynch syndrome-related cancer diagnosed before the age of 50 is another criterion. Familial adenomatous polyposis ( FAP ), another inherited genetic disorder that can cause colon cancer, must be excluded. All tumors must be verified by pathological examination. Meeting one or more of these criteria may indicate an increased risk of Lynch syndrome and further testing or screening may be recommended. It is important for individuals with a family history of Lynch syndrome-related cancers to discuss their risk with a healthcare professional and undergo appropriate surveillance and management to reduce their risk of developing cancer.</p>\n<p><strong>Extraedge:</strong></p><p>Treatment for serous cystic neoplasms typically involves periodic imaging tests to monitor the cyst's growth and potential for malignancy. Surgery may be recommended if the cyst is large or causing symptoms or if there is concern about the potential for malignancy. Overall, the prognosis for individuals with serous cystic neoplasms is generally good, as most cysts are benign and do not require treatment beyond monitoring.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47c8cf68",
      "audio": ""
    },
    {
      "text": "The most common site for metastasis in the Carcinoma rectum:",
      "options": [
        {
          "label": "A",
          "text": "Adrenals",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lung",
          "correct": false
        },
        {
          "label": "C",
          "text": "Liver",
          "correct": true
        },
        {
          "label": "D",
          "text": "Brain",
          "correct": false
        }
      ],
      "correct_answer": "C. Liver",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Liver</p>\n<p><strong>Highyeild:</strong></p><p>The most common site for metastasis in carcinoma rectum is the liver . The veins that drain the rectum flow directly into the liver, allowing cancer cells to easily spread to this organ. Other common sites of metastasis in rectal cancer include the lungs, bones, and lymph nodes. However, the liver remains the most frequent site of metastasis and is closely monitored during the staging and treatment of rectal cancer.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: A & B. The principal sites for blood-borne metastases are the liver (34%), lungs (22%), and adrenals (11%). Option: D. The remaining 33% are divided among the many other locations where secondary carcinomatous deposits tend to lodge, including the brain.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d09900a2",
      "audio": ""
    }
  ]
}